×
About 15,905 results

ALLMedicine™ Neutropenia Center

Research & Reviews  5,597 results

Racial disparity in taxane-induced neutropenia among cancer patients.
https://doi.org/10.1002/cam4.4181
Cancer Medicine; Zheng NS, Wang F et. al.

Sep 22nd, 2021 - Large interindividual variations have been reported in chemotherapy-induced toxicities. Little is known whether racial disparities exist in neutropenia associated with taxanes. Patients with a diagnosis of primary cancer who underwent chemotherapy...

Hypoparathyroidism, neutropenia and nephrotic syndrome in a patient with mitochondrial ...
https://doi.org/10.1016/j.ejmg.2021.104344
European Journal of Medical Genetics; Li Y, He C et. al.

Sep 21st, 2021 - Mitochondrial trifunctional protein (TFP) deficiency is an autosomal recessive disorder that causes a clinical spectrum of diseases ranging from severe infantile cardiomyopathy to mild chronic progressive neuromyopathy, however, parathyroid glands...

Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-pos...
https://doi.org/10.1007/s10549-021-06387-1 10.1056/NEJMoa0910383 10.1186/1471-2407-11-404 10.1002/cncr.21847 10.1016/j.critrevonc.2010.02.002 10.1038/sj.bjc.6601279 10.1007/s10549-017-4646-1 10.1093/jnci/90.16.1205 10.1056/nejm199107183250305 10.1200/jco.2006.08.8823 10.1093/annonc/mdt226 10.1007/s00520-014-2457-z 10.1002/14651858.CD007913.pub2 10.1007/s00520-015-2686-9 10.1093/annonc/mdy311 10.2165/11590130-000000000-00000 10.1200/jco.2015.62.3488 10.1093/cid/cir073 10.1093/annonc/mdw325 10.1016/j.ejca.2010.10.013 10.1200/jco.2006.09.9994 10.2217/bmt.14.22 10.1371/journal.pmed.1000100 10.1371/journal.pmed.1000097 10.1093/annonc/mdt182 10.1056/NEJMoa1703643 10.1016/s1470-2045(17)30716-7 10.1007/s10549-020-05524-6 10.1007/s10549-011-1862-y 10.1007/s10549-013-2582-2 10.4048/jbc.2014.17.4.356 10.1007/s10549-016-4098-z 10.1007/s10549-016-3866-0 10.1111/tbj.12927 10.6004/jnccn.2017.7010 10.1016/j.clbc.2018.04.016 10.1007/s00520-019-05111-6 10.1002/cnr2.1266 10.1097/xeb.0000000000000141 10.1056/NEJMoa1113216 10.1016/s1470-2045(11)70336-9 10.1007/s00520-011-1375-6 10.1007/s10549-015-3531-z
Breast Cancer Research and Treatment; Van Belle H, Hurvitz SA et. al.

Sep 18th, 2021 - Docetaxel, carboplatin and trastuzumab, with or without pertuzumab (TCH(P)), has become the preferred (neo)adjuvant regimen for HER2-positive breast cancer. However, its associated febrile neutropenia (FN) risk is unclear: pivotal studies reported...

Do age, fitness and concomitant medications influence management and outcomes of CLL pa...
https://doi.org/10.1182/bloodadvances.2021004824
Blood Advances; Tedeschi A, Frustaci AM et. al.

Sep 16th, 2021 - Functional reserve of organs and systems is known to be relevant in predicting immunochemotherapy tolerance. Age and comorbidities, assessed by the cumulative illness rating scale (CIRS), have been used to address chemotherapy intensity. In ibruti...

Gastrointestinal Surgical Emergencies in the Neutropenic Immunocompromised Patient.
https://doi.org/10.1007/s11605-021-05116-9 10.1097/MOH.0000000000000012 10.1001/archsurg.1990.01410210045006 10.1097/SLA.0b013e3181724fe5 10.1038/bmt.2008.235 10.1016/j.leukres.2005.08.029 10.1136/tsaco-2020-000439 10.1038/s41395-018-0122-8 10.1007/s11605-009-1009-1 10.1177/000313481608201038 10.1016/j.jss.2011.03.061 10.1007/s11605-018-04081-0 10.1111/j.1600-0609.2005.00442.x 10.1086/514946 10.1046/j.1365-2141.2002.03434.x 10.1093/annonc/mdl337 10.1093/cid/cis998 10.1002/1097-0142(19920101)69:1<17::aid-cncr2820690106>3.0.co;2-x 10.1002/1097-0142(197902)43:2<695::aid-cncr2820430242>3.0.co;2-9 10.1159/000331587 10.1097/MPH.0b013e3181b1ee28 10.1007/BF01358883 10.1002/1097-0142(19860201)57:3<603::aid-cncr2820570335>3.0.co;2-k 10.1080/17474086.2017.1280389 10.1245/s10434-007-9510-9 10.1111/jgs.13615 10.5858/arpa.2015-0451-RA 10.1186/s13054-017-1678-1 10.1245/s10434-019-08183-0 10.1093/annonc/mdm508 10.1200/JCO.2005.23.754 10.1007/BF02236900 10.1007/BF02049810 10.1016/j.ejso.2013.01.001 10.1016/0002-9610(86)90217-5 10.1007/978-3-319-98343-1_118 10.1097/DCR.0000000000000733 10.1245/s10434-009-0626-y 10.1038/nrgastro.2017.126 10.1056/NEJMra1609337 10.3109/10428199809058388 10.1016/j.jpedsurg.2017.06.022 10.1245/s10434-020-08328-6 10.1016/j.jamcollsurg.2020.03.036
Journal of Gastrointestinal Surgery : Official Journal Of... White MG, Morgan RB et. al.

Sep 11th, 2021 - Surgeons encounter neutropenic patients through elective or emergency consultation with increasing regularity. As medical management continues to extend the lives of patients with benign hematologic diseases, hematologic malignancies, solid malign...

see more →

Guidelines  14 results

Emerging challenges in the evaluation of fever in cancer patients at risk of febrile ne...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682766
Supportive Care in Cancer : Official Journal of the Multi... Cooksley T, Font C et. al.

Nov 25th, 2020 - Patients with cancer are at higher risk of more severe COVID-19 infection and have more associated complications. The position paper describes the management of cancer patients, especially those receiving anticancer treatment, during the COVID-19 ...

Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism.
https://doi.org/10.1210/clinem/dgaa543
The Journal of Clinical Endocrinology and Metabolism; Brar PC, Heksch R et. al.

Aug 19th, 2020 - The diagnosis of hypoglycemia and the use of diazoxide have risen in the last decade. Diazoxide is the only Food and Drug Agency-approved pharmacologic treatment for neonatal hypoglycemia caused by hyperinsulinism (HI). Recent publications have hi...

ACR Appropriateness Criteria® Acute Nonlocalized Abdominal Pain.
https://doi.org/10.1016/j.jacr.2018.09.010
Journal of the American College of Radiology : JACR; , Scheirey CD et. al.

Nov 6th, 2018 - The range of pathology in adults that can produce abdominal pain is broad and necessitates an imaging approach to evaluate many different organ systems. Although localizing pain prompts directed imaging/management, clinical presentations may vary ...

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASC...
https://doi.org/10.1200/JCO.18.00374
Journal of Clinical Oncology : Official Journal of the Am... Taplitz RA, Kennedy EB et. al.

Sep 5th, 2018 - To provide an updated joint ASCO/Infectious Diseases Society of America (IDSA) guideline on antimicrobial prophylaxis for adult patients with immunosuppression associated with cancer and its treatment. ASCO and IDSA convened an update Expert Panel...

Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: Americ...
https://doi.org/10.1200/JCO.2017.77.6211
Journal of Clinical Oncology : Official Journal of the Am... Taplitz RA, Kennedy EB et. al.

Feb 21st, 2018 - Purpose To provide an updated joint ASCO/Infectious Diseases Society of American (IDSA) guideline on outpatient management of fever and neutropenia in patients with cancer. Methods ASCO and IDSA convened an Update Expert Panel and conducted a syst...

see more →

Drugs  243 results see all →

News  508 results

Lifileucel Promising Against Unresponsive Malignant Melanoma
https://www.medscape.com/viewarticle/952183

Jun 2nd, 2021 - NEW YORK (Reuters Health) - Lifileucel shows promise in metastatic-melanoma patients whose disease had progressed on standard immune-checkpoint inhibitors (ICI) and other therapies, according to a small open-label trial. "Lifileucel is a ground-br...

Lobaplatin 'Promising' in Nasopharyngeal Cancer
https://www.medscape.com/viewarticle/950478

May 4th, 2021 - Lobaplatin-based induction plus chemoradiation was as effective as, and safer than, a cisplatin-based regimen in a phase 3 trial of more than 500 patients with advanced nasopharyngeal carcinoma. The lobaplatin regimen proved to be a "promising alt...

Gemcitabine Maintenance After First-Line Chemo Prolongs PFS in Malignant Mesothelioma
https://www.medscape.com/viewarticle/945372

Feb 8th, 2021 - NEW YORK (Reuters Health) - Gemcitabine maintenance therapy after first-line chemotherapy significantly prolonged progression-free survival (PFS) in patients with malignant mesothelioma, according to results of the Dutch NVALT19 trial. "Almost all...

Convenience, Cost Sway Choice of G-CSF Added to Chemo
https://www.medscape.com/viewarticle/945109

Feb 2nd, 2021 - The choice of whether to use granulocyte colony-stimulating factor (G-CSF) for the prevention of febrile neutropenia for patients undergoing chemotherapy depends on whether it is being used for primary or secondary prophylaxis, indicates a survey ...

Jury's Still Out on Trifluridine/Tipiracil Plus Bev in mCRC
https://www.medscape.com/viewarticle/944927

Jan 29th, 2021 - First-line trifluridine/tipiracil plus bevacizumab (TT-B) offered a slight survival benefit over capecitabine plus bevacizumab (C-B) in patients with unresectable metastatic colorectal cancer in the final analysis of the TASCO1 trial. The median p...

see more →